ciprofloxacin has been researched along with Blood Clot in 9 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The incidence of the adverse reactions was not related to the duration of the infusion (30 or 60 min), but was less (frequency and extent) when the anticubital vein was used for infusion rather than when smaller more peripheral veins were employed." | 1.27 | Tolerance of ciprofloxacin at injection site, systemic safety and effect on electroencephalogram. ( Bergan, T; Johannesson, G; Rohwedder, R; Thorsteinsson, HS; Thorsteinsson, SB, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Navarro-Navajas, A | 1 |
| Casallas, I | 1 |
| Isaza, D | 1 |
| Ortiz, P | 1 |
| Baracaldo-Santamaría, D | 1 |
| Calderon-Ospina, CA | 1 |
| Alagl, A | 1 |
| Bedi, S | 1 |
| Hassan, K | 1 |
| AlHumaid, J | 1 |
| Neelamurthy, PS | 1 |
| Kumar, RA | 1 |
| Balakrishnan, V | 1 |
| Venkatesan, SM | 1 |
| Narayan, GS | 1 |
| I, K | 1 |
| Singh, B | 1 |
| Varshney, L | 1 |
| Sharma, V | 1 |
| Miesbach, W | 1 |
| Tulsidas, H | 1 |
| Ong, YY | 1 |
| Chan, KC | 1 |
| Henrickson, KJ | 1 |
| Axtell, RA | 1 |
| Hoover, SM | 1 |
| Kuhn, SM | 1 |
| Pritchett, J | 1 |
| Kehl, SC | 1 |
| Klein, JP | 1 |
| Daikos, GL | 1 |
| Kathpalia, SB | 1 |
| Lolans, VT | 1 |
| Jackson, GG | 1 |
| Fosslien, E | 1 |
| Thorsteinsson, SB | 1 |
| Bergan, T | 1 |
| Johannesson, G | 1 |
| Thorsteinsson, HS | 1 |
| Rohwedder, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Short Daily Alcohol Locks for the Prevention of Tunneled Catheter Infection in Patients With Haematological Disease. Randomised Placebo Controlled Trial[NCT00122642] | Phase 2/Phase 3 | 440 participants (Anticipated) | Interventional | 2005-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ciprofloxacin and Blood Clot
| Article | Year |
|---|---|
Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial.
Topics: Anti-Infective Agents; Bacteremia; Catheterization, Central Venous; Child; Child, Preschool; Ciprofl | 2000 |
8 other studies available for ciprofloxacin and Blood Clot
| Article | Year |
|---|---|
Type III Kounis Syndrome Secondary to Ciprofloxacin-Induced Hypersensitivity.
Topics: Acute Coronary Syndrome; Aged; Ciprofloxacin; Humans; Hypersensitivity; Kounis Syndrome; Myocardial | 2022 |
Use of platelet-rich plasma for regeneration in non-vital immature permanent teeth: Clinical and cone-beam computed tomography evaluation.
Topics: Aluminum Compounds; Anti-Bacterial Agents; Bone Density; Calcium Compounds; Cefaclor; Child; Ciprofl | 2017 |
Revascularization in Immature and Mature Teeth with Necrotic Pulp: A Clinical Study.
Topics: Adolescent; Adult; Aluminum Compounds; Anti-Bacterial Agents; Calcium Compounds; Child; Ciprofloxaci | 2018 |
Design of sterile mucoadhesive hydrogels for use in drug delivery: effect of radiation on network structure.
Topics: Adhesives; Animals; Ciprofloxacin; Differential Thermal Analysis; Diffusion; Drug Delivery Systems; | 2014 |
Rituximab in the treatment of factor XIII inhibitor possibly caused by Ciprofloxacin.
Topics: Anti-Infective Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoantibodie | 2005 |
Aeromonas hydrophila bacteraemia and portal pyaemia.
Topics: Aeromonas hydrophila; Aged; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Gram-Negative Bacteria | 2008 |
Long-term oral ciprofloxacin: experience in the treatment of incurable infective endocarditis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Drug Administration Schedule; E | 1988 |
Tolerance of ciprofloxacin at injection site, systemic safety and effect on electroencephalogram.
Topics: Adult; Ciprofloxacin; Electrocardiography; Erythema; Female; Forearm; Humans; Injections, Intravenou | 1987 |